- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT05106933
The Effect of Carbohydrate Loading 2 Hours Before Gastroscopy on Gastric Residual Volume and Patient's Well-being Score (Carborie)
The Effect of Carbohydrate Loading 2 Hours Before Upper Endoscopy on Gastric Residual Volume and Patient's Well-being Score : A Single-Blind, Randomized Controlled Trial Study
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Yksityiskohtainen kuvaus
Patient planned for OGDS in HUSM will be randomized into 2 groups. Plain water is given to group A of subject and carbohydrate loading is given to group B subject 2 hours before OGDS. Gastric residual volume is visualized directly and measured through aspiration via OGDS and subject's well-being is assessed for both group of the subject prior and after clear fluid have been given.
Methodology :
Research design :- This is a single-blind randomized controlled trial. This is a stratified (diabetes mellitus, non-diabetes mellitus) with balanced randomization (1:1), placebo-controlled study Study area :- This study will be conducted in the endoscopy room, Hospital Universiti Sains Malaysia (HUSM) in Kubang Kerian, Kelantan, Malaysia
All subjected planned for OGDS with the complaint of one or more of the following symptoms : Bothersome postprandial fullness, early satiety, epigastric pain or epigastric burning and fulfill the inclusion criteria are selected. Patients will be approached and be explained regarding the study in surgical outpatient clinic before OGDS. The patient will be approached again on the day of OGDS, if agree to participate, informed consent will be obtained. Informed consent will be obtained after explanation regarding the study and procedure again by researcher nurse.
The allocation sequence is according to computer-generated random number list, it was prepared by an investigator with no clinical involvement in the trial. The allocation sequence was concealed from researcher enrolling and assessing participants. The allocation sequence will be sealed in sequentially numbered and opaque envelopes. A manila card will be placed inside envelop to render it impermeable to intense light. To prevent subversion of the allocation sequence, the name and identification number of the participants will be written on a book together with the series number on the envelope. The details in the book will be kept confidentially.
After enrolled subject complete all the baseline assessment, the corresponding envelope will be enclosed by the trained staff (who not involved in the study) who prepare the drink. The staff need to ensure that the envelop is still sealed when receiving it. The staff will prepare the drink into an identical container according to the assignment.
The subjects are randomized into 2 groups: 1 group with 400mL plain water and another group given 1 packet carborie (400mL). Subjects need to finish the drink over 10 minutes. After that, subjects are not allowed to leave endoscope room until finish OGDS to prevent consumption of other drink or food.
2 hours after that, the subject undergoes OGDS. OGDS is performed following the standard protocol.
- The patient lies in the left lateral position
- Medication/lignocaine spray to numb the back of throats (spray) will be given to prevent gagging during the passage of the instrument
- A plastic mouth guard (mouthpiece) is placed between the teeth to prevent damage to the teeth and endoscope
- The endoscope (also called a gastroscope) will be inserted through the mouthpiece
- A small container or yankauer suction is placed close to the mouth of a patient to collect saliva during and after the oesophagogastroduodenoscopy (OGDS)
- The endoscope will be inserted along the middle line of the soft palate
- Once endoscope advanced, the patient may be asked to swallow to facilitate advancement of scope
- Throughout the procedure, no water flushing is allowed, only air inflation is allowed.
Visualized pooling of fluid in the stomach is aspirated until dry via direct visualization with the endoscope. The aspirated fluid will be collected in the suction reservoir and the fluid will be measured
Subject's well-being score is assessed via visual analogue scale (VAS) which consist of 5 parameters: hunger, thirst, anxiety, tiredness and general discomfort. This scale will be used repeatedly during this study to assess the patient's well-being. The trained staff nurse will ask the patient regarding the level of 5 parameters and subject need to mark [X] somewhere along the horizontal line given before drink and before OGDS procedure.
All subjects are advised to inform assessor if there is an adverse reaction. Medical personnel are available to manage any adverse events that might occur throughout the procedure.
The possible risk that may arise in the study includes injury to the gastrointestinal wall, aspiration and bleeding which is the similar risk for all patient undergoing for OGDS procedure. The small volume of the drink will not cause psychological distress to the subject, but its taste may not be palatable.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Kelantan
-
Kota Bharu, Kelantan, Malesia, 15200
- Department of General Surgery
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Patient 18 years old and above
- Agree to participate
Exclusion Criteria:
- History of upper gastrointestinal surgery
- Patient with active gastrointestinal bleeding
- Unstable clinical condition
- Mentally disable or who cannot give an informed consent
- Patient on the nasogastric feeding tube
- Pregnant patient
- American Society of Anesthesiologists classification of physical status grade 3 or above
- Insulin dependent Diabetes Mellitus more than 10 years
- Patient who is carbohydrate intolerance
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Nelinkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Placebo Comparator: Plain water
Group A patient will be given 400cc of plain water, 2 hours prior to gastroscopy
|
Measure gastric residual volume during upper endoscopic, after given plain water and carborie 2 hours prior upper endoscopy
|
|
Kokeellinen: Carborie
Group B patient will be given 400cc of carborie (carbohydrate drink), 2 hours prior to gastroscopy
|
carbohydrate drink
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
To compare the gastric residual volume 2 hours after carbohydrate loading (intervention group) and plain water group (control group)
Aikaikkuna: 2 hour before OGDS
|
Patients will be randomised into control group and intervention group.
Those in intervention group will have to drink clear water containing carbohydrate (carborie) 2 hours prior to gastroscopy.
Endoscopist will measure patient's gastric residual volume.
Residual gastric fluid will be aspirated into the container, final volume will be measured.
|
2 hour before OGDS
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
To compare the patient's well-being after ingestion of carbohydrate loading (intervention group) and plain water (control group)
Aikaikkuna: 2 hours
|
To assess patient well-being score before and after giving carborie load.
Visual analogue scale (VAS) used for assessment of patient well-being.
Just before and after the ingestion of the clear fluid patients are told to indicate the level of discomfort on a visual analogue scale which ranged from 0mm to 100mm.
Zero signifying not at all while 100 signify the most imaginable/maximum discomfort.
|
2 hours
|
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
To assess the effect of carbohydrate loading in patient planned for OGDS in HUSM
Aikaikkuna: 2 hours prior OGDS
|
To assess gastric residual volume 2 hour prior OGDS
|
2 hours prior OGDS
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Opintojohtaja: Nizam Hashim, Master, HUSM, Kubang Kerian, Malaysia
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2011 Mar;114(3):495-511. doi: 10.1097/ALN.0b013e3181fcbfd9. No abstract available.
- Qureshi WA, Zuckerman MJ, Adler DG, Davila RE, Egan JV, Gan SI, Lichtenstein DR, Rajan E, Shen B, Fanelli RD, Van Guilder T, Baron TH; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2006 Apr;63(4):566-9. doi: 10.1016/j.gie.2006.02.001. No abstract available.
- De Silva AP, Amarasiri L, Liyanage MN, Kottachchi D, Dassanayake AS, de Silva HJ. One-hour fast for water and six-hour fast for solids prior to endoscopy provides good endoscopic vision and results in minimum patient discomfort. J Gastroenterol Hepatol. 2009 Jun;24(6):1095-7. doi: 10.1111/j.1440-1746.2009.05782.x. Epub 2009 Feb 12.
- Sabry R, Hasanin A, Refaat S, Abdel Raouf S, Abdallah AS, Helmy N. Evaluation of gastric residual volume in fasting diabetic patients using gastric ultrasound. Acta Anaesthesiol Scand. 2019 May;63(5):615-619. doi: 10.1111/aas.13315. Epub 2019 Jan 4.
- Spada C, McNamara D, Despott EJ, Adler S, Cash BD, Fernandez-Urien I, Ivekovic H, Keuchel M, McAlindon M, Saurin JC, Panter S, Bellisario C, Minozzi S, Senore C, Bennett C, Bretthauer M, Dinis-Ribeiro M, Domagk D, Hassan C, Kaminski MF, Rees CJ, Valori R, Bisschops R, Rutter MD. Performance measures for small-bowel endoscopy: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. United European Gastroenterol J. 2019 Jun;7(5):614-641. doi: 10.1177/2050640619850365. Epub 2019 May 15.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- HUSM Malaysia
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Mahalaukun jäännöstilavuus
-
Second Affiliated Hospital, School of Medicine,...ValmisFundal Gastric Varices | Endoskooppisen ultraäänen (EUS) ohjaama kierrutus | Titaaniklipit | Ektopinen embolisointi | MahalaskimopaineKiina
-
Xianmin Song, MDRekrytointi
-
Peking University First HospitalXiangya Hospital of Central South University; Peking Union Medical College... ja muut yhteistyökumppanitTuntematonPerioperatiiviset/postoperatiiviset komplikaatiot | PORC (Postoperative Residual Curarization)Kiina
-
M.D. Anderson Cancer CenterValmisPaksusuolen syöpä | Resektoitu vaiheYhdysvallat
-
University of UlmLopetettu
-
Astellas Pharma Global Development, Inc.Ei ole enää käytettävissäAkuutti myelooinen leukemia (AML) | FMS:n kaltaiset tyrosiinikinaasi-3 (FLT3) -mutaatiotAustralia, Italia, Yhdistynyt kuningaskunta
-
Boston Medical CenterValmis
-
Astellas Pharma Global Development, Inc.Hyväksytty markkinointiinAkuutti myelooinen leukemia (AML) | FMS:n kaltaiset tyrosiinikinaasi-3 (FLT3) -mutaatiotYhdysvallat, Kanada, Japani
-
AmgenLopetettuB-prekursori akuutti lymfoblastinen leukemiaYhdysvallat
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCAktiivinen, ei rekrytointi
Kliiniset tutkimukset Plain water
-
Instituto de Cardiologia do Rio Grande do SulValmisHarjoituksen jälkeinen hypotensioBrasilia
-
Procter and GambleValmis
-
University of NebraskaPeruutettu
-
Water Pik, Inc.Valmis
-
McMaster UniversityThe Hospital for Sick Children; University of Alberta; Western UniversityValmis
-
Water Pik, Inc.Lopetettu
-
University of British ColumbiaB.C. Rehabilitation FoundationValmisSatunnaistettu kontrolloitu vesiprotokollan kokeilu asiakkaille, joilla on ohut nestemäinen dysfagiaOhut nestemäinen dysfagiaKanada
-
All Sum Research Center Ltd.Water Pik, Inc.ValmisPehmytkudosvauriot
-
Nicolaus Copernicus UniversityLopetettu
-
University Hospital, AntwerpTuntematonVestibulaarinen häiriöBelgia